Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 1

Status

Completed 14Recruiting 12Unknown 10Not yet recruiting 6Active not recruiting 4Terminated 3Withdrawn 1Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 2Head & Neck 2Dermatologic 1

Conditions

Breast Neoplasms 705Carcinoma, Non-Small-Cell Lung 473Prostatic Neoplasms 423Neoplasms 384Multiple Myeloma 266Colorectal Neoplasms 257Lung Neoplasms 245Neoplasm Metastasis 234Melanoma 219Leukemia, Myeloid, Acute 193Ovarian Neoplasms 189Pancreatic Neoplasms 177Squamous Cell Carcinoma of Head and Neck 160Carcinoma, Renal Cell 146Recurrence 144Lymphoma 144Glioblastoma 142Lymphoma, Non-Hodgkin 136Stomach Neoplasms 128Triple Negative Breast Neoplasms 127Leukemia, Lymphocytic, Chronic, B-Cell 123Brain Neoplasms 123Carcinoma, Hepatocellular 122Head and Neck Neoplasms 116Uterine Cervical Neoplasms 115Urinary Bladder Neoplasms 115Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Lymphoma, Large B-Cell, Diffuse 104Sarcoma 103Lymphoma, Follicular 100

Interventions

Radiosurgery 1Microscopy, Confocal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Margins of Excision × Clear all
NCT04073745 2026-04-30

Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 1 Active not recruiting
50 enrolled
Thoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07242053 2026-04-28

Margin Intraoperative CT Feedback Feedback Study

University Health Network, Toronto

Phase NA Active not recruiting
80 enrolled
Thoracic

Margins of Excision, Disease, Lung Neoplasms

NCT05935995 2025-11-28

HISTOBLOC

Institut de Cancérologie de Lorraine

Phase NA Active not recruiting
42 enrolled
DermatologicHead & Neck

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell

NCT05459415 2022-07-15

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Active not recruiting
54 enrolled
Head & Neck

Margins of Excision, Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡